Literature DB >> 7856751

Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study.

R García del Moral1, F O'Valle, M Andújar, M Aguilar, M A Lucena, J López-Hidalgo, C Ramírez, M T Medina-Cano, D Aguilar, M Gómez-Morales.   

Abstract

P-glycoprotein (P-gp), encoded in humans by the mdr-1 gene, acts physiologically as an efflux pump to expel hydrophobic substances from cells. This glycoprotein is closely related to multidrug resistance in tumor cells and can be modulated by cyclosporin A (CsA). We investigated the relationship between CsA and P-gp in 52 renal allograft biopsies and in cultures of Madin-Darby canine kidney (MDCK) renal tubule cells to determine whether the intrarenal accumulation of CsA or chronic stimulation with the drug modified the expression of P-gp. Expression of P-gp and CsA was analyzed by immunohistochemistry. Immunostaining was evaluated semiquantitatively. Modulation of P-gp in MDCK cells after chronic stimulation with CsA for 7, 30, and 60 days was analyzed by flow cytometry. P-gp and CsA immunostaining in renal post-transplant biopsies showed considerable overlap in all cases (Spearman's test, r = 0.577, P < 0.001). After 7 days in vitro, the number of cells expressing P-gp increased progressively; a further increase in mean fluorescence was found after 60 days (P < 0.001, Student's t-test). Our findings suggest that in non-neoplastic cells, CsA may stimulate P-gp as a mechanism of detoxification. Individual differences in the adaptive responses to glycoprotein may be responsible for the appearance of nephrotoxicity or a CsA-resistant rejection reaction in cases of overexpression on lymphocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856751      PMCID: PMC1869856     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection.

Authors:  J Kemnitz; A Uysal; A Haverich; B Heublein; T R Cohnert; W Stangel; A Georgii
Journal:  J Heart Lung Transplant       Date:  1991 Mar-Apr       Impact factor: 10.247

Review 2.  Pharmacokinetics of cyclosporine: inter- and intra-individual variations and metabolic pathways.

Authors:  M Lemaire; A Fahr; G Maurer
Journal:  Transplant Proc       Date:  1990-06       Impact factor: 1.066

3.  Structural elements pertinent to the interaction of cyclosporin A with its specific receptor protein, cyclophilin.

Authors:  V L Hsu; S L Heald; M W Harding; R E Handschumacher; I M Armitage
Journal:  Biochem Pharmacol       Date:  1990-07-01       Impact factor: 5.858

4.  Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation.

Authors:  J C Reed; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  In vitro cyclosporine toxicity. The effect of verapamil.

Authors:  J E Scoble; J C Senior; P Chan; Z Varghese; P Sweny; J F Moorhead
Journal:  Transplantation       Date:  1989-04       Impact factor: 4.939

6.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

7.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

Authors:  C Cordon-Cardo; J P O'Brien; J Boccia; D Casals; J R Bertino; M R Melamed
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479

8.  Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.

Authors:  H Herweijer; P Sonneveld; F Baas; K Nooter
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

9.  Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer.

Authors:  M G Daidone; R Silvestrini; O Sanfilippo; N Zaffaroni; M Varini; M De Lena
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

10.  Cell biological mechanisms of multidrug resistance in tumors.

Authors:  S M Simon; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

View more
  3 in total

1.  Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation.

Authors:  Benedetta C Sallustio; Benjamin D Noll; Janet K Coller; Jonathan Tuke; Graeme Russ; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

2.  Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.

Authors:  R G del Moral; M Andujar; C Ramírez; M Gómez-Morales; M Masseroli; M Aguilar; A Olmo; F Arrebola; M Guillén; M J García-Chicano; F F Nogales; F O'Valle
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

3.  The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.

Authors:  Arik Dahan; Hairat Sabit; Gordon L Amidon
Journal:  AAPS J       Date:  2009-03-25       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.